Combined assessment of beta-D-glucan and degree of candida colonization before starting empiric therapy for candidiasis in surgical patients

World Journal of Surgery
Yoshio TakesueTaijiro Sueda

Abstract

The purpose of the study was to investigate whether examination for plasma beta-D-glucan, a cell wall constituent of fungi, is useful for selecting surgical patients with Candida colonization who would benefit from empiric antifungal therapy. We administered fluconazole to postoperative patients with Candida colonization who have risk factors for candidemia and complained of persistent fever despite prolonged antibacterial therapy. We then analyzed the clinical outcomes regarding the number of sites colonized with Candida spp. and plasma beta-D-glucan. Of the 32 patients positive for alpha-D-glucan, 15 (46.9%) responded to the empiric therapy; only 9% of those who were negative responded (p < 0.01). In the multiple logistic regression analysis, being positive for alpha-D-glucan was a significant factor predicting response, with an adjusted odds ratio of 12.9 in patients with Candida colonization [95% confidence interval (CI) 2.07-80.73) (p < 0.01). In addition, the number of sites colonized with Candida spp. was a significant factor predicting response, with an estimated exposure odds ratio of 7.57 for those who were colonized at three or more sites compared with those colonized at one site (95% CI 1.20-47.70) (p = 0.031). In p...Continue Reading

References

Sep 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·V J FraserW C Dunagan
Jul 1, 1991·Reviews of Infectious Diseases·J E KarpP Charache
Oct 1, 1989·Archives of Internal Medicine·S B WeyR P Wenzel
Jul 30, 1981·Biochemical and Biophysical Research Communications·A KakinumaY Sugino
Dec 1, 1996·American Journal of Surgery·J S Solomkin
May 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C ViscoliM Congiu
Feb 6, 1998·World Journal of Surgery·D A Dean, K W Burchard
Aug 15, 1998·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·T KawagoeH Takagi
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H RexJ E Edwards

❮ Previous
Next ❯

Citations

Oct 24, 2008·Current Infectious Disease Reports·Coleman Rotstein
May 26, 2009·Revista iberoamericana de micología·Amalia Del PalacioAlmudena Alhambra
Dec 28, 2007·Journal of Clinical Microbiology·Florence PersatAnnie Sulahian
Jun 21, 2013·American Journal of Respiratory and Critical Care Medicine·Frederic TissotUNKNOWN Fungal Infection Network of Switzerland (FUNGINOS)
May 3, 2013·Current Medical Research and Opinion·John R Perfect
Nov 17, 2009·Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi·Takeshi AsanoOsamu Fujino
Jul 4, 2015·BMC Infectious Diseases·Yi Xin LiewWinnie Lee
May 16, 2006·Pathologie-biologie·S Anane, F Khalfallah
May 5, 2009·International Journal of Antimicrobial Agents·Po-Ren HsuehAlexander Angelo Padiglione
May 31, 2007·The Annals of Pharmacotherapy·Ryosuke TsurutaTsuyoshi Maekawa
May 18, 2010·Hospital Practice·Sujatha Krishnan, Luis Ostrosky-Zeichner
Nov 4, 2008·Current Opinion in Infectious Diseases·Elliott Geoffrey PlayfordThierry Calandra
Sep 4, 2009·Current Opinion in Infectious Diseases·Luis Ostrosky-Zeichner
Nov 19, 2009·Cellular Microbiology·Weidong Zhu, Scott G Filler
Apr 30, 2010·Drugs·E Geoffrey PlayfordTania C Sorrell
Sep 8, 2010·Medical Mycology·Luis Ostrosky-ZeichnerJohn R Perfect
Nov 10, 2015·The Journal of Critical Care Medicine·Péter HankovszkyZsolt Molnár
Feb 12, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R McMullanR J Hay
Jan 23, 2009·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Yoshio Takesue
Jun 12, 2016·The Journal of Antimicrobial Chemotherapy·Marcio NucciArnaldo L Colombo
Nov 2, 2004·Obstetrics and Gynecology·Koji NishijimaFumikazu Kotsuji

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.